GlideScope BFlex Single-Use Bronchoscope System

K183256 · Verathon Medical (Canada) Ulc · EOQ · Jan 4, 2019 · Ear, Nose, Throat

Device Facts

Record IDK183256
Device NameGlideScope BFlex Single-Use Bronchoscope System
ApplicantVerathon Medical (Canada) Ulc
Product CodeEOQ · Ear, Nose, Throat
Decision DateJan 4, 2019
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 874.4680
Device ClassClass 2
Attributes3rd-Party Reviewed

Intended Use

GlideScope® BFlex™ Single-Use Bronchoscope System are intended to work with the video monitor, in conjunction with non-powered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree in adult patients.

Device Story

System comprises single-use flexible bronchoscope, reusable video monitor, and reusable cable. Device captures real-time airway images via distal camera and LED light source; transmits video to monitor for display and recording. Used by clinicians for airway procedures. Provides visualization to assist in navigation and placement of non-powered endoscopic accessories. Single-use design eliminates reprocessing requirements, reducing cross-contamination risk. Output allows physician to perform diagnostic or therapeutic airway interventions.

Clinical Evidence

No clinical data. Substantial equivalence supported by bench testing, including system requirements, hardware/software verification, electromagnetic compatibility (ANSI AAMI IEC 60601-1-2), electrical safety (AAMI/ANSI ES60601-1, IEC 60601-2-18), optical performance (ISO 8600-3/4), biocompatibility (ANSI AAMI ISO 10993-1), and sterile packaging integrity.

Technological Characteristics

Flexible endoscope; 5.5mm outer diameter; 2.1mm working channel. Features: suction button, tip maneuverability control, LED light source, camera. Power: rechargeable Lithium-ion battery (via monitor). Connectivity: wired connection to reusable monitor. Sterilization: Ethylene Oxide (EO). Software: embedded firmware for image processing/display.

Indications for Use

Indicated for endoscopy within the airways and tracheobronchial tree in adult patients.

Regulatory Classification

Identification

A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logos of the U.S. Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font size below. January 4, 2019 Verathon Medical (Canada) ULC % Mark Job Responsible Third Party Official Regulatory Technology Services, LLC 1394 25th Street, NW Buffalo, MN 55313 Re: K183256 Trade/Device Name: GlideScope BFlex™ Single-Use Bronchoscope System Regulation Number: 21 CFR 874.4680 Regulation Name: Bronchoscope (flexible or rigid) and accessories Regulatory Class: Class II Product Code: EOO Dated: December 14, 2018 Received: December 21, 2018 Dear Mark Job: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely yours. # Srinivas Nandkumar -S for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ #### Indications for Use 510(k) Number (if known) K183256 #### Device Name GlideScope® BFlex™ Single-Use Bronchoscope System Indications for Use (Describe) GlideScope® BFlex™ Single-Use Bronchoscope System are intended to work with the video monitor, in conjunction with non-powered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree in adult patients. Type of Use (Select one or both, as applicable) | <span style="font-size: 16px;"> <input checked="true" type="checkbox"/> </span> Prescription Use (Part 21 CFR 801 Subpart D) | |------------------------------------------------------------------------------------------------------------------------------| | <span style="font-size: 16px;"> <input type="checkbox"/> </span> Over-The-Counter Use (21 CFR 801 Subpart C) | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for Verathon. The logo consists of a stylized "V" shape on the left, followed by the word "VERATHON" in blue, sans-serif font. The "V" shape is also in blue and appears to be made up of two intersecting lines. # SECTION E: 510(K) SUMMARY This summary of Safety and Effectiveness is provided as part of this Premarket Notification in compliance with 21 CFR 807, Subpart E, section 807.92. #### Submitter: Verathon Medical (Canada) ULC 2227 Douglas Road Burnaby, BC V3W 1P2 Canada #### Contact Person: Teresa Davidson Director, Regulatory Affairs Phone: (425) 629-5516 Email: teresa.davidson@verathon.com #### Date Summary Prepared: October 26, 2018 #### Establishment Registration Number: Verathon Medical (Canada) ULC Registration Number: 9615393 Owner/Operator Number: 9095489 #### Device Trade or Proprietary Name: GlideScope® BFlex™ Single-Use Bronchoscope System #### Device Common or Usual Name: Flexible Bronchoscope #### Device Classification: | Classification Name | Class | Product Code | Classification Regulation | |-----------------------------------------------------|-------|--------------|---------------------------| | Bronchoscope (Flexible or<br>Rigid) and Accessories | II | EOQ | 21 CFR 874.4680 | {4}------------------------------------------------ Image /page/4/Picture/0 description: The image shows the logo for Verathon. The logo consists of a stylized "V" shape on the left, followed by the word "VERATHON" in blue, sans-serif font. The "V" shape is also in blue and has a sharp, pointed design. ## Review Panel: Ear, Nose, and Throat ## Predicate Device: The features and functions of the proposed GlideScope® BFlex™ Single-Use Bronchoscope System is substantially equivalent to the previously cleared Ambu® aScope™ 3 5.0/2.2 flexible bronchoscope and monitor system. The 510(k) clearance number and respective clearance date for the predicate device is below: | Predicate Device | 510(k) Number | Clearance Date | |----------------------------------------------------------------------------------|---------------|-------------------| | Ambu® aScope™ 3 5.0/2.2*<br>Ambu® aScope™ 3 Slim 3.8/1.2<br>Ambu® aView™ Monitor | K130845 | November 01, 2013 | * The specific Ambu® aScope™ 3 5.0/2.2 is the predicate device size for the proposed GlideScope® BFlex™ Single-Use Bronchoscope System. This size scope is labeled as Reqular in Ambu labeling. # Device Description: The GlideScope® BFlex™ Single-Use Bronchoscope System consists of a single-use flexible bronchoscope (5.0), a reusable monitor, and a reusable cable. The system is intended to provide real time viewing and recording for a wide range of airway procedures. The GlideScope® BFlex™ Single-Use Bronchoscope System is distributed sterile and is for single use only. The BFlex bronchoscope operates with a portable reusable GlideScope video monitor (GVM) for purposes of image display. ## Intended Use: GlideScope® BFlex™ Single-Use Bronchoscope System are intended to work with the video monitor, in conjunction with non-powered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree in adult patients. ## Technological Characteristics: The proposed subject GlideScope® BFlex™ Single-Use Bronchoscope System when compared to the predicate bronchoscope system has similar technological characteristics. See the comparison table below for similarities and differences between the subject and predicate devices. {5}------------------------------------------------ Image /page/5/Picture/0 description: The image contains the logo for Verathon. The logo consists of a stylized "V" shape on the left, followed by the word "VERATHON" in blue, sans-serif font. The "V" shape is formed by two intersecting lines, with the left line extending downwards to form a vertical line. | Technological<br>Characteristic | Predicate Device Ambu<br>aScope 3 System<br>(K130845) | GlideScope® BFlex™<br>Single Use Sytem<br>(This submission) | |-----------------------------------------------|-------------------------------------------------------|-------------------------------------------------------------| | Flexible Endoscope | Yes | Yes | | Outside diameter of<br>flexible shaft and tip | 5.0mm | 5.5mm | | Inside diameter of<br>working channel | 2.0mm | 2.1mm | | Suction Button | Yes | Yes | | Single Use<br>Bronchoscope | Yes | Yes | | Sterility | Sterile by Ethylene Oxide (EO) | Same | | Control button for tip<br>maneuverability | Yes | Yes | | Power Source | Rechargeable Lithium-ion<br>battery | Same | | Camera | Yes | Yes | | LED Light Source | Yes | Yes | | Image Display | Displays image on a reusable<br>monitor | Same | | Extended Viewing | Yes | Yes | ### Performance Testing: Performance testing has been completed to demonstrate that the proposed GlideScope® BFlex™ Single-Use Bronchoscope System meets the safety and performance requirements established in the design specifications. Comprehensive verification and validation testing included the following: - System Requirements Testing - . Hardware Verification - Software Verification - AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment - Part 1: General requirements for basic safety and essential performance) - IEC 60601-2-18: Edition 3.0 2009-08 Medical electrical equipment - Part 2-18: Particular requirements for the basic safety and essential performance of endoscopic equipment - ANSI AAMI IEC 60601-1-2:2007/(R)2012 ● {6}------------------------------------------------ Image /page/6/Picture/0 description: The image shows the logo for Verathon. The logo consists of a stylized green symbol resembling a stylized letter "V" or a plant shoot on the left, followed by the word "VERATHON" in blue, sans-serif font. A small registration mark is present to the upper right of the word "VERATHON". - Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility -Requirements and tests (Edition 3) - . ISO 8600-1 Fourth Edition 2015-10-15 Endoscopes - Medical endoscopes and endotherapy devices -- Part 1: General requirements - SO 8600-3 First edition 1997-07-01 (Amendment 1 2003-12-01 . Optics and Optical instruments - Medical endoscopes and endoscopic accessories -Part 3: Determination of field of view and direction of view of endoscopes with optics [Including: Amendment 1 (2003)] - ISO 8600-4 Second Edition 2014-03-15 ● Endoscopes - Medical endoscopes and certain accessories - Part 4: Determination of maximum width of insertion portion - ANSI AAMI ISO 10993-1:2009/(R)2013 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process - Aging Performance Testing ● - Sterile Packaging Integrity Testing - Cleaning Testing - Design Validation Results: All testing resulted in acceptance criteria passed. # Summary of Clinical Tests: The GlideScope® BFlex™ Single-Use Bronchoscope System, subject of this submission, did not require clinical studies to support the determination of substantial equivalence. # Conclusion: The information in this 510(k) Premarket Notification demonstrates that the proposed GlideScope® BFlex™ Single-Use Bronchoscope System is substantially equivalent to the previously cleared predicate Ambu® aScope™ 3 5.0/2.2, Ambu® aScope™ 3 Slim 3.8/1.2, and Ambu® aView™ Monitor bronchoscope system with respect to safety, effectiveness and performance.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...